Methylglyoxal has deleterious effects on thioredoxin in human aortic endothelial cells

Environmental Toxicology and Pharmacology

Volumn 34, Issue 2, 2012, Pages 117-126

  Oba, Tatsuya ^a   Tatsunami, Ryosuke ^a   Sato, Keisuke ^a   Takahashi, Kyohei ^a   Hao, Zhihui ^b   Tampo, Yoshiko ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Human aortic endothelial cells; Methylglyoxal; Oxidative stress; Peroxiredoxin; Thioredoxin

Indexed keywords

CYTOCHROME C; LIPOCORTIN 5; METHYLGLYOXAL; PEROXIREDOXIN; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN; MESSENGER RNA; 3 DEOXYGLUCOSONE; GLYOXAL; HYDROETHIDINE;

APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; CELL DEATH; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; INCUBATION TIME; INTRACELLULAR MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; TRANSCRIPTION REGULATION; AORTA; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; AORTA ENDOTHELIAL CELL; CARBOHYDRATE ANALYSIS; CYTOKINE RELEASE; CYTOSOL; CYTOTOXICITY; FLUORESCENCE; LIGHT INTENSITY; OXIDATION; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM;

AORTA; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CYTOCHROMES C; ENDOTHELIAL CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PEROXIREDOXINS; PYRUVALDEHYDE; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; THIOREDOXINS;

EID: 84859736570     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2012.03.007     Document Type: Article

References (48)

1. Baden, T., Yamawaki, H., Saito, K., Mukohda, M., Okada, M., Hara, Y., 2008. Telmisartan inhibits methylglyoxal-mediated cell death in human vascular endothelium. Biochem. Biophys. Res. Commun. 373, 253-257.
2. Barranco-Medina, S., Lazaro, J.J., Dietz, K.J., 2009. The oligomeric conformation of peroxiredoxins links redox state to function. FEBS Lett. 583, 1809-1816.
3. Beisswenger, P.J., Howell, S.K., O'Dell, R.M.,Wood, M.E., Touchette, A.D., Szwergold, B.S., 2001. α-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 24, 726-732.
4. Berndt, C., Lillig, C.H., Holmgren, A., 2007. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 292, H1227-H1236.
5. Brouwers, O., Niessen, P.M., Ferreira, I., Miyata, T., Scheffer, P.G., Teerlink, T., Schrauwen, P., Brownlee, M., Stehouwer, C.D., Schalkwijk, C.G., 2010. Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. J. Biol. Chem. 286, 1374-1380.
6. Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
7. Cantero, A.V., Portero-Otín, M., Ayala, V., Auge, N., Sanson, M., Elbaz, M., Thiers, J.C., Pamplona, R., Salvayre, R., Nègre-Salvayre, A., 2007. Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. FASEB J. 21, 3096-3106.
8. Ceriello, A., 2006. Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Curr. Opin. Lipidol. 17, 510-518.
9. Chang, T., Wu, L., 2006. Methylglyoxal, oxidative stress, and hypertension. Can. J. Physiol. Pharmacol. 84, 1229-1238.
10. Chaplen, F.W., Fahl, W.E., Cameron, D.C., 1998. Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells. Proc. Natl. Acad. Sci. U.S.A. 95, 5533-5538.
11. Che, W., Asahi, M., Takahashi, M., Kaneto, H., Okado, A., Higashiyama, S., Taniguchi, N., 1997. Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogenesis in diabetes. J. Biol. Chem. 272, 18453-18459.
12. Connolly, D.T., Knight, M.B., Harakas, N.K., Wittwer, A.J., Feder, J., 1986. Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal. Biochem. 152, 136-140.
13. Cox, A.G., Pearson, A.G., Pullar, J.M., Jönsson, T.J., Lowther, W.T., Winterbourn, C.C., Hampton, M.B., 2009. Mitochondrial peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic peroxiredoxins. Biochem. J. 421, 51-58.
14. Cox, A.G., Pullar, J.M., Hughes, G., Ledgerwood, E.C., Hampton, M.B., 2008. Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor-mediated apoptosis. Free Radic. Biol. Med. 44, 1001-1009.
15. Dhanasekaran, A., Kotamraju, S., Karunakaran, C., Kalivendi, S.V., Thomas, S., Joseph, J., Kalyanaraman, B., 2005. Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. Free Radic. Biol. Med. 39, 567-583.
16. Ding, Y., Yamada, S., Wang, K.Y., Shimajiri, S., Guo, X., Tanimoto, A., Murata, Y., Kitajima, S., Watanabe, T., Izumi, H., Kohno, K., Sasaguri, Y., 2010. Overexpression of peroxiredoxin 4 protects against high-dose streptozotocin-induced diabetes by suppressing oxidative stress and cytokines in transgenic mice. Antioxid. Redox Signal. 13, 1477-1490.
17. Fukunaga, M., Miyata, S., Liu, B.F., Miyazaki, H., Hirota, Y., Higo, S., Hamada, Y., Ueyama, S., Kasuga, M., 2004. Methylglyoxal induces apoptosis through activation of [38p] MAPK in rat Schwann cells. Biochem. Biophys. Res. Commun. 320, 689-695.
18. Green, D.R., Reed, J.C., 1998. Mitochondria and apoptosis. Science 281, 1309-1312.
19. Jabeen, R., Mohammad, A.A., Elefano, E.C., Petersen, J.R., Saleemuddin, M., 2006. Antibodies and Fab fragments protect Cu, Zn-SOD against methylglyoxal-induced inactivation. Biochim. Biophys. Acta 1760, 1167-1174.
20. Kakisaka, Y., Nakashima, T., Sumida, Y., Yoh, T., Nakamura, H., Yodoi, J., Senmaru, H., 2002. Elevation of serum thioredoxin levels in patients with type 2 diabetes. Horm. Metab. Res. 34, 160-164.
21. Kalapos, M.P., 2008. Methylglyoxal and glucose metabolism: a historical perspective and future avenues for research. Drug Metabol. Drug Interact. 23, 69-91.
22. Lincoln, D.T., Ali Emadi, E.M., Tonissen, K.F., Clarke, F.M., 2003. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res. 23, 2425-2433.
23. Liu, Y., Min, W., 2002. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ. Res. 90, 1259-1266.
24. McLellan, A.C., Thornalley, P.J., Benn, J., Sonksen, P.H., 1994. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. (Lond.) 87, 21-29.
25. Mirza, M.A., Kandhro, A.J., Memon, S.Q., Khuhawar, M.Y., Arain, R., 2007. Determination of glyoxal and methylglyoxal in the serum of diabetic patients by MEKC using stilbenediamine as derivatizing reagent. Electrophoresis 28, 3940-3947.
26. Mukohda, M., Yamawaki, H., Nomura, H., Okada, M., Hara, Y., 2009. Methylglyoxal inhibits smooth muscle contraction in isolated blood vessels. J. Pharmacol. Sci. 109, 305-310.
27. Myers, C.R., Myers, J.M., 2009. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells. Toxicology 257, 95-104.
28. Nakamura, H., Nakamura, K., Yodoi, J., 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351-369.
29. Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M.A., Beebe, D., Oates, P.J., Hammes, H.P., Giardino, I., Brownlee, M., 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790.
30. Odani, H., Shinzato, T., Matsumoto, Y., Usami, J., Maeda, K., 1999. Increase in three α,β-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem. Biophys. Res. Commun. 256, 89-93.
31. Okado, A., Kawasaki, Y., Hasuike, Y., Takahashi, M., Teshima, T., Fujii, J., Taniguchi, N., 1996. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem. Biophys. Res. Commun. 225, 219-224.
32. Ota, K., Nakamura, J., Li, W., Kozakae, M., Watarai, A., Nakamura, N., Yasuda, Y., Nakashima, E., Naruse, K., Watabe, K., Kato, K., Oiso, Y., Hamada, Y., 2007. Metformin prevents methylglyoxal-induced apoptosis of mouse Schwann cells. Biochem. Biophys. Res. Commun. 357, 270-275.
33. Park, Y.S., Koh, Y.H., Takahashi, M., Miyamoto, Y., Suzuki, K., Dohmae, N., Takio, K., Honke, K., Taniguchi, N., 2003. Identification of the binding site of methylglyoxal on glutathione peroxidase: methylglyoxal inhibits glutathione peroxidase activity via binding to glutathione binding sites Arg 184 and 185. Free Radic. Res. 37, 205-211.
34. Rosca, M.G., Mustata, T.G., Kinter, M.T., Ozdemir, A.M., Kern, T.S., Szweda, L.I., Brownlee, M., Monnier, V.M., Weiss, M.F., 2005.Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am. J. Physiol. Renal Physiol. 289, F420-F430.
35. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., Ichijo, H., 1998. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606.
36. Sasaki, N.A., Garcia-Alvarez, M.C., Wang, Q., Ermolenko, L., Franck, G., Nhiri, N., Martin, M.T., Audic, N., Potier, P., 2009. N-terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation. Bioorg. Med. Chem. 17, 2310-2320.
37. Schulze, P.C., Yoshioka, J., Takahashi, T., He, Z., King, G.L., Lee, R.T., 2004. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J. Biol. Chem. 279, 30369-30374.
38. Sena, C.M., Matafome, P., Louro, T., Nunes, E., Fernandes, R., Seiça, R.M., 2011. Metformin restores endothelial function in aorta of diabetic rats. Br. J. Pharmacol. 163, 424-437.
39. Shinohara, M., Thornalley, P.J., Giardino, I., Beisswenger, P., Thorpe, S.R., Onorato, J., Brownlee, M., 1998. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest. 101, 1142-1147.
40. Tao, L., Gao, E., Bryan, N.S., Qu, Y., Liu, H.R., Hu, A., Christopher, T.A., Lopez, B.L., Yodoi, J., Koch, W.J., Feelisch, M., Ma, X.L., 2004. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation. Proc. Natl. Acad. Sci. U.S.A. 101, 11471-11476.
41. Tatsunami, R., Oba, T., Takahashi, K., Tampo, Y., 2009. Methylglyoxal causes dysfunction of thioredoxin and thioredoxin reductase in endothelial cells. J. Pharmacol. Sci. 111, 426-432.
42. Wang, X.L., Lau, W.B., Yuan, Y.X., Wang, Y.J., Yi, W., Christopher, T.A., Lopez, B.L., Liu, H., 2010. Methylglyoxal increases cardiomyocyte ischemia-reperfusion injury via glycative inhibition of thioredoxin activity. Am. J. Physiol. Endocrinol. Metab. 299, E207-E214.
43. Wood, Z.A., Schroder, E., Robin Harris, J., Poole, L.B., 2003. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32-40.
44. Yamawaki, H., Haendeler, J., Berk, B.C., 2003. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ. Res. 93, 1029-1033.
45. Yamawaki, H., Saito, K., Okada, M., Hara, Y., 2008. Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells. Am. J. Physiol. Cell Physiol. 295, C1510-C1517.
46. Yoshida, T., Oka, S., Masutani, H., Nakamura, H., Yodoi, J., 2003. The role of thioredoxin in the aging process: involvement of oxidative stress. Antioxid. Redox Signal. 5, 563-570.
47. Zhao, H., Joseph, J., Fales, H.M., Sokoloski, E.A., Levine, R.L., Vásquez-Vivar, J., Kalyanaraman, B., 2005. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc. Natl. Acad. Sci. U.S.A. 102, 5727-5732.
48. Zou, H., Henzel, W.J., Liu, X., Lutschg, A., Wang, X., 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413.